Literature DB >> 22294156

Human tau may modify glucocorticoids-mediated regulation of cAMP-dependent kinase and phosphorylated cAMP response element binding protein.

Yudong Liu1, Ying Su, Shenggang Sun, Tao Wang, Xian Qiao, Hui Li, Xiaoqin Run, Zhihou Liang.   

Abstract

Phosphorylation of the cAMP response element binding protein (CREB) by cAMP-dependent kinase (PKA) is critical to memory formation. However, activation of PKA can also increase tau phosphorylation, which may contribute to memory impairment. Therefore, the regulation of PKA may be part of the mechanism by which glucocorticoids (GCs) influence memory. Additionally, the cellular response to GCs may be affected by the presence of human tau. The goal of this paper was to study GCs-mediated regulation of PKA as well as CREB and tau phosphorylation in wild-type HEK293 cells and HEK293 cells stably expressing human tau441 (HEK293/tau441 cells). By using dexamethasone (DEX) as GCs, we found that DEX induced a tau-dependent selective decrease in the level of PKA RIIβ subunit protein. The observed decrease in RIIβ expression was not due to alterations of mRNA levels and was reversed by inhibiting the proteasome with lactacystin. Moreover, the decrease in RIIβ did not diminish the co-localization of the catalytic subunit of PKA with tau and might contribute to the DEX-induced increase in tau phosphorylation at Ser-214. DEX also induced a tau-dependent decrease in CREB phosphorylation that could not be reversed by activating PKA with forskolin. Taken together, these results show that human tau protein may alter the GCs-mediated regulation of PKA activity and CREB phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22294156     DOI: 10.1007/s11064-011-0686-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  45 in total

1.  Glucocorticoid enhancement of memory consolidation in the rat is blocked by muscarinic receptor antagonism in the basolateral amygdala.

Authors:  A E Power; B Roozendaal; J L McGaugh
Journal:  Eur J Neurosci       Date:  2000-10       Impact factor: 3.386

2.  Effects of tau phosphorylation on proteasome activity.

Authors:  Qing-Guo Ren; Xiao-Mei Liao; Xiao-Qian Chen; Gong-Ping Liu; Jian-Zhi Wang
Journal:  FEBS Lett       Date:  2007-03-05       Impact factor: 4.124

Review 3.  Tailoring cAMP-signalling responses through isoform multiplicity.

Authors:  M D Houslay; G Milligan
Journal:  Trends Biochem Sci       Date:  1997-06       Impact factor: 13.807

Review 4.  Specificity in the cAMP/PKA signaling pathway. differential expression, regulation, and subcellular localization of subunits of PKA.

Authors:  B S Skålhegg; K Taskén
Journal:  Front Biosci       Date:  1997-07-01

5.  Berberine attenuates calyculin A-induced cytotoxicity and Tau hyperphosphorylation in HEK293 cells.

Authors:  Guang Yu; Yi Li; Qing Tian; Rong Liu; Qun Wang; Jian-Zhi Wang; Xiaochuan Wang
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

6.  Adverse neurodevelopmental effects of dexamethasone modeled in PC12 cells: identifying the critical stages and concentration thresholds for the targeting of cell acquisition, differentiation and viability.

Authors:  Ruth R Jameson; Frederic J Seidler; Dan Qiao; Theodore A Slotkin
Journal:  Neuropsychopharmacology       Date:  2005-11-30       Impact factor: 7.853

Review 7.  Post-translational modifications of tau protein in Alzheimer's disease.

Authors:  C-X Gong; F Liu; I Grundke-Iqbal; K Iqbal
Journal:  J Neural Transm (Vienna)       Date:  2004-10-27       Impact factor: 3.575

8.  Recruitment of cAMP-response element-binding protein and histone deacetylase has opposite effects on glucocorticoid receptor gene transcription.

Authors:  Manjapra Variath Govindan
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

9.  Norepinephrine-glucocorticoids interaction does not annul the opposite effects of the individual treatments on cellular plasticity in neuroblastoma cells.

Authors:  Shiri P Yaniv; Dorit Ben-Shachar; Ehud Klein
Journal:  Eur J Pharmacol       Date:  2008-08-20       Impact factor: 4.432

10.  Down-regulation of IL-2 production in T lymphocytes by phosphorylated protein kinase A-RIIbeta.

Authors:  Michael R Elliott; Ryan A Shanks; Islam U Khan; James W Brooks; Pamela J Burkett; Brandy J Nelson; Vasileios Kyttaris; Yuang-Taung Juang; George C Tsokos; Gary M Kammer
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

View more
  2 in total

1.  Tau phosphorylation and μ-calpain activation mediate the dexamethasone-induced inhibition on the insulin-stimulated Akt phosphorylation.

Authors:  Yudong Liu; Ying Su; Shenggang Sun; Tao Wang; Xian Qiao; Xiaoqin Run; Zhihou Liang
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

Review 2.  Activation of mTOR: a culprit of Alzheimer's disease?

Authors:  Zhiyou Cai; Guanghui Chen; Wenbo He; Ming Xiao; Liang-Jun Yan
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-09       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.